Emotional disorders.
Conditions
Interventions
Intervention 1: Intervention group: They will receive the Transdiagnostic Unified Protocol (UP) based on the therapist's guide (Barlow et al., 2018) in the form of 12 weekly 60-minute group sessions (
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Adults aged 18 years and older. Meeting DSM-5 diagnostic criteria for at least one emotional disorder, including depressive disorders, anxiety spectrum disorders, obsessive-compulsive spectrum disorders, trauma-related disorders, eating disorders, or borderline personality disorder. Scoring above the clinical cutoff (= 27) on the Irrational Procrastination Scale, indicating severe procrastination as the primary presenting complaint. Ability to read and write in Persian. Ability and willingness to provide written informed consent for participation in the study. Residence in Tehran Province and ability to attend intervention sessions. If taking psychiatric medications (e.g., SSRIs), being on a stable dosage for at least 6 weeks prior to study entry.
Exclusion criteria
Exclusion criteria: Diagnosis of psychotic disorders (e.g., schizophrenia), bipolar disorder, or substance use disorders (based on DSM-5 criteria) that may interfere with the intervention. Presence of active suicidal ideation or planning, or a history of suicide attempt within the past 6 months. Receiving ongoing regular psychotherapy during the study period that may interfere with the Unified Protocol intervention. Presence of chronic medical conditions (e.g., cardiovascular or neurological diseases) that may prevent participation in intervention sessions. Inability to comprehend or respond to the research instruments in Persian. Presence of cognitive impairments (e.g., dementia) that may interfere with participation in the intervention or completion of questionnaires. Having received more than 4 sessions of cognitive behavioral therapy (CBT) or more than 6 months of psychodynamic psychotherapy within the past year.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of depressive symptoms using the Beck Depression Inventory (BDI-II). Timepoint: The depression score at the beginning of the study, after the end of the study, and three months after the end. Method of measurement: Beck Depression Inventory.;Severity of anxiety symptoms with Beck Anxiety Inventory (BAI). Timepoint: Anxiety score at the beginning of the study, after the end of the study, and three months after the end. Method of measurement: Beck Anxiety Inventory.;Procrastination severity with the Irrational Procrastination Scale (IPS). Timepoint: Procrastination score at the beginning of the study, after the end of the study, and three months after the end. Method of measurement: Irrational Procrastination Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Banafsheh Mohajerin
Shahid Beheshti University of Medical Sciences
Outcome results
None listed